Test Result Reproducibility Rate is crucial for assessing the reliability of experimental outcomes, influencing operational efficiency and data-driven decision-making.
High reproducibility fosters trust in results, enhancing stakeholder confidence and driving strategic alignment.
This KPI serves as a leading indicator for research quality, impacting both financial health and business outcomes.
Organizations that prioritize reproducibility can reduce costs associated with failed experiments and improve forecasting accuracy.
A robust reproducibility rate can also streamline management reporting, ensuring that insights are actionable and reliable.
High values indicate a strong ability to replicate results, reflecting rigorous methodologies and robust data integrity. Conversely, low values may suggest underlying issues in experimental design or execution, which can lead to costly rework. Ideal targets often hover around 90% or higher, signaling a high degree of confidence in findings.
We have 5 relevant benchmarks in our benchmarks database.
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | threshold; average | mixed | study period | laboratory total error (TE) scores | clinical chemistry | multi-country (Netherlands, Portugal, Spain, UK) |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | average; median; range | mixed | programme period reported | laboratory EQA performance scores | public health and veterinary laboratories (One Health) | South and South-East Asia |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | average; range | mixed | 2023 EQA exercise | species identification results | clinical microbiology (AST surveillance) | EU/EEA | 869 laboratories |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | threshold | per PT event | laboratory PT event scores | clinical laboratories | United States |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | threshold | per PT event | participating laboratories’ PT results | clinical laboratories | United States |
Many organizations overlook the importance of reproducibility, focusing instead on immediate results. This can lead to long-term inefficiencies and misallocated resources.
Enhancing reproducibility requires a systematic approach to research practices and data management.
A leading pharmaceutical company faced challenges with its Test Result Reproducibility Rate, which had dipped to 65%. This decline raised concerns about the reliability of its drug development processes, jeopardizing both timelines and budgets. To address this, the company initiated a comprehensive review of its research protocols, focusing on standardizing methodologies across laboratories.
The initiative involved cross-functional teams working together to identify best practices and implement new training programs for researchers. By emphasizing the importance of documentation and data integrity, the company aimed to create a culture of accountability and precision. Additionally, they invested in advanced data management tools to streamline processes and reduce human error.
Within a year, the reproducibility rate improved to 85%, significantly enhancing stakeholder confidence in the research outcomes. The company was able to accelerate its drug development pipeline, reducing time-to-market for several key products. This not only improved financial ratios but also positioned the company as a leader in innovation within the industry.
The success of the initiative demonstrated the value of focusing on reproducibility as a key performance indicator. By embedding these practices into their KPI framework, the organization achieved better alignment with strategic goals and improved overall operational efficiency.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Reproducibility ensures that findings are reliable and can be trusted by stakeholders. It enhances the credibility of research and supports data-driven decision-making.
Standardizing protocols and investing in training are effective strategies. Encouraging open communication about methodologies also fosters a culture of reproducibility.
Data management systems and reporting dashboards can provide insights into reproducibility rates. These tools help identify trends and areas for improvement.
No, reproducibility is vital across various industries, including pharmaceuticals, manufacturing, and technology. It affects product quality and operational efficiency.
Regular assessments, ideally quarterly, help maintain high standards. Frequent reviews allow organizations to address issues proactively.
Low reproducibility can lead to wasted resources and delayed projects. It may also damage an organization's reputation and stakeholder trust.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)